• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

应用激光捕获显微切割和分子生物学技术研究人甲状腺乳头状癌中雌激素受体-α的过度表达。

Overexpression of estrogen receptor-α in human papillary thyroid carcinomas studied by laser- capture microdissection and molecular biology.

机构信息

Department of Experimental Medicine, Sapienza University of Rome, Rome, Italy.

出版信息

Cancer Sci. 2011 Oct;102(10):1921-7. doi: 10.1111/j.1349-7006.2011.02017.x. Epub 2011 Jul 27.

DOI:10.1111/j.1349-7006.2011.02017.x
PMID:21707866
Abstract

The expression pattern of estrogen receptor (ER) isoforms in normal and tumor thyroid tissues is still controversial and poor defined, therefore, a more detailed study of the distribution of these molecules is needed. Most discrepancies might be due to the methods utilized. We studied the expression of ER isoforms in human papillary thyroid carcinoma (PTC), in fine-needle aspiration biopsy-derived specimens, and in cells, using more accurate techniques, such as laser-capture microdissection, real-time quantitative PCR, and Western blot. Laser-capture microdissection allowed us to isolate homogeneous cell populations from human PTC surgical samples. Tumor, peritumor, or normal host tissue of the same sample were separately dissected and analyzed by RT-PCR and Western blot. Estrogen receptor-α mRNA was more expressed in cancer-microdissected cells from human PTC, as compared with microdissected cells obtained from surrounding normal host tissue (450 vs 12, P = 0.001). A similar pattern was observed with Western blot for the ER-a protein. By contrast, ER-β mRNA expression was not detected among the microdissected tissue fractions. Fine-needle aspiration biopsy-derived specimens showed a similar expression pattern to ER. Moreover, human PTC cell line BCPAP and cancer stem cells from PTC, analyzed under hypoxic conditions, showed a hypoxia-driven increase in ER-α expression. In conclusion, ER-α might have an important role in human PTC, and its overexpression can be studied in routine needle aspirate as a possible marker of malignancy.

摘要

雌激素受体 (ER) 异构体在正常和肿瘤甲状腺组织中的表达模式仍存在争议且定义不明确,因此需要对这些分子的分布进行更详细的研究。大多数差异可能是由于所使用的方法不同。我们使用更准确的技术,如激光捕获显微切割、实时定量 PCR 和 Western blot,研究了人甲状腺乳头状癌 (PTC) 中 ER 异构体的表达。激光捕获显微切割允许我们从人 PTC 手术样本中分离出同质的细胞群。分别对肿瘤、肿瘤周围或同一样本的正常宿主组织进行切割,并通过 RT-PCR 和 Western blot 进行分析。与从周围正常宿主组织中获得的微切割细胞相比,人 PTC 中癌症微切割细胞中的 ER-α mRNA 表达更高(450 比 12,P = 0.001)。用 ER-a 蛋白的 Western blot 也观察到了类似的模式。相比之下,在微切割组织部分中未检测到 ER-β mRNA 的表达。细针抽吸活检衍生标本显示出与 ER 相似的表达模式。此外,在缺氧条件下分析的人 PTC 细胞系 BCPAP 和 PTC 的癌症干细胞显示 ER-α 表达的缺氧驱动增加。总之,ER-α 在人 PTC 中可能具有重要作用,其过表达可在常规针吸活检中作为恶性肿瘤的可能标志物进行研究。

相似文献

1
Overexpression of estrogen receptor-α in human papillary thyroid carcinomas studied by laser- capture microdissection and molecular biology.应用激光捕获显微切割和分子生物学技术研究人甲状腺乳头状癌中雌激素受体-α的过度表达。
Cancer Sci. 2011 Oct;102(10):1921-7. doi: 10.1111/j.1349-7006.2011.02017.x. Epub 2011 Jul 27.
2
Overexpression of pro-inflammatory genes and down-regulation of SOCS-1 in human PTC and in hypoxic BCPAP cells.促炎基因在人甲状腺乳头状癌和低氧 BCPAP 细胞中的过表达和 SOCS-1 的下调。
Biomed Pharmacother. 2013 Feb;67(1):7-16. doi: 10.1016/j.biopha.2012.08.003. Epub 2012 Sep 16.
3
Concomitant high expression of ERα36, GRP78 and GRP94 is associated with aggressive papillary thyroid cancer behavior.同时高表达 ERα36、GRP78 和 GRP94 与侵袭性甲状腺乳头状癌的行为相关。
Cell Oncol (Dordr). 2018 Jun;41(3):269-282. doi: 10.1007/s13402-017-0368-y. Epub 2018 Jan 24.
4
[Clinicopathologic and molecular features of cribriform morular variant of papillary thyroid carcinoma].[甲状腺乳头状癌筛状桑葚状变异型的临床病理及分子特征]
Zhonghua Bing Li Xue Za Zhi. 2018 May 8;47(5):354-359. doi: 10.3760/cma.j.issn.0529-5807.2018.05.008.
5
Quantitative analysis of estrogen receptor-alpha and -beta messenger RNA expression in normal and malignant thyroid tissues by real-time polymerase chain reaction.通过实时聚合酶链反应对正常和恶性甲状腺组织中雌激素受体-α和-β信使核糖核酸表达进行定量分析。
Oncology. 2001;61(4):293-8. doi: 10.1159/000055336.
6
Assessment of RET/PTC oncogene activation in thyroid nodules utilizing laser microdissection followed by nested RT-PCR.利用激光显微切割技术,随后进行巢式逆转录聚合酶链反应,评估甲状腺结节中RET/PTC癌基因的激活情况。
Methods Mol Biol. 2005;293:103-11. doi: 10.1385/1-59259-853-6:103.
7
[Expression of microRNA-221 and IL-17 in papillary thyroid carcinoma and correlation with clinicopathologic features].[微小RNA-221和白细胞介素-17在甲状腺乳头状癌中的表达及其与临床病理特征的相关性]
Zhonghua Bing Li Xue Za Zhi. 2017 Mar 8;46(3):160-165. doi: 10.3760/cma.j.issn.0529-5807.2017.03.004.
8
Long non-coding RNA BANCR regulates cancer stem cell markers in papillary thyroid cancer via the RAF/MEK/ERK signaling pathway.长链非编码 RNA BANCR 通过 RAF/MEK/ERK 信号通路调节甲状腺乳头状癌中的癌症干细胞标志物。
Oncol Rep. 2018 Aug;40(2):859-866. doi: 10.3892/or.2018.6502. Epub 2018 Jun 18.
9
miR-219-5p modulates cell growth of papillary thyroid carcinoma by targeting estrogen receptor α.微小RNA-219-5p通过靶向雌激素受体α调控甲状腺乳头状癌的细胞生长。
J Clin Endocrinol Metab. 2015 Feb;100(2):E204-13. doi: 10.1210/jc.2014-2883. Epub 2014 Nov 25.
10
Differential expression patterns and clinical significance of estrogen receptor-α and β in papillary thyroid carcinoma.雌激素受体-α和β在甲状腺乳头状癌中的差异表达模式及临床意义
BMC Cancer. 2014 May 29;14:383. doi: 10.1186/1471-2407-14-383.

引用本文的文献

1
Risk factors for secondary thyroid cancer in patients with breast cancer: a propensity‑matched SEER analysis.乳腺癌患者继发甲状腺癌的风险因素:一项倾向评分匹配 SEER 分析。
Sci Rep. 2024 Jun 3;14(1):12679. doi: 10.1038/s41598-024-59209-x.
2
Sex-Specific Expression of Histone Lysine Demethylases (KDMs) in Thyroid Cancer.组蛋白赖氨酸去甲基化酶(KDMs)在甲状腺癌中的性别特异性表达
Cancers (Basel). 2024 Mar 23;16(7):1260. doi: 10.3390/cancers16071260.
3
Androgen Receptor Activation Induces Senescence in Thyroid Cancer Cells.雄激素受体激活诱导甲状腺癌细胞衰老。
Cancers (Basel). 2023 Apr 7;15(8):2198. doi: 10.3390/cancers15082198.
4
Links between Breast and Thyroid Cancer: Hormones, Genetic Susceptibility and Medical Interventions.乳腺癌与甲状腺癌之间的联系:激素、遗传易感性及医学干预措施
Cancers (Basel). 2022 Oct 19;14(20):5117. doi: 10.3390/cancers14205117.
5
The Isoforms of Estrogen Receptor Alpha and Beta in Thyroid Cancer.甲状腺癌中雌激素受体α和β的亚型
Front Oncol. 2022 Jun 24;12:916804. doi: 10.3389/fonc.2022.916804. eCollection 2022.
6
Puberty and sex in pediatric thyroid cancer: could expression of estrogen and progesterone receptors affect prognosis?儿童甲状腺癌中的青春期与性征:雌激素和孕激素受体的表达会影响预后吗?
Eur Thyroid J. 2022 Mar 8;11(2):e210090. doi: 10.1530/ETJ-21-0090.
7
Sex Bias in Differentiated Thyroid Cancer.甲状腺癌的性别偏见。
Int J Mol Sci. 2021 Nov 30;22(23):12992. doi: 10.3390/ijms222312992.
8
Can We Predict Differentiated Thyroid Cancer Behavior? Role of Genetic and Molecular Markers.我们能否预测分化型甲状腺癌的行为?遗传和分子标志物的作用。
Medicina (Kaunas). 2021 Oct 19;57(10):1131. doi: 10.3390/medicina57101131.
9
Papillary Thyroid Cancer-Promoting Activities of Combined Oral Contraceptive Components.复方口服避孕药成分促进甲状腺乳头状癌的作用
Galen Med J. 2020 May 21;9:e1648. doi: 10.31661/gmj.v9i0.1648. eCollection 2020.
10
Estrogen Receptor Beta: The Promising Biomarker and Potential Target in Metastases.雌激素受体β:转移中的有前途的生物标志物和潜在靶点。
Int J Mol Sci. 2021 Feb 6;22(4):1656. doi: 10.3390/ijms22041656.